Clinical Trial Update: Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating durvalumab in combination with chemotherapy for locally advanced or metastatic solid tumors; the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Chemotherapy (unspecified)
• Imfinzi (durvalumab) (durvalumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 2 | Status: RECRUITING